ICON Partners with Korea National Enterprise for Clinical Trials

[at noodls] – Partnership aims to further advance clinical research in South Korea Dublin, Ireland, 3 October, 2012 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services … more

View todays social media effects on ICLR

View the latest stocks trending across Twitter. Click to view dashboard